Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.8B | 3.3B | 4.7B | 4.4B |
Cost of revenue | 2.7B | 1.8B | 2.5B | 2.4B |
Gross profit | 2.2B | 1.4B | 2.1B | 2.0B |
Operating expense | ||||
Research & development | 16.8M | 12.6M | 20.4M | 18.6M |
Selling general and admin | 928.9M | -644.6M | 1.6B | 54.4M |
Other operating expenses | 46.8M | 49.4M | 32.8M | 54.1M |
Operating income | 1.2B | 687.3M | 1.1B | 1.2B |
Non operating interest income | ||||
Income | 47.3M | 53.5M | 69.8M | 76.8M |
Expense | 21.3M | -68.5M | 70.9M | -16.1M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 753.3M | 1.2B | 1.3B |
Tax provision | 253.2M | 134.3M | 235.2M | 245.5M |
Net income | 980.0M | 619.0M | 976.8M | 1.1B |
Basic EPS | 1.9 | — | — | — |
Diluted EPS | 1.9 | — | — | — |
Basic average shares | 520.0M | — | — | — |
Diluted average shares | 520.0M | — | — | — |
EBITDA | 1.2B | 679.6M | 1.3B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 54.2K | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |